Glenmark Life Sciences signs MSA with Japanese pharma company EP News Bureau Jan 19, 2024 To manufacture and supply API in the therapeutic area of urinary anti-spasmodic
Glenmark to divest majority stake in Glenmark Life Sciences to Nirma EP News Bureau Sep 22, 2023 Nirma will acquire 75 per cent stake in Glenmark Life Sciences at a price of Rs 615/- per share
